Drug intelligence / Profile preview

BVX-0320

Development stage: Preclinical
Lead developer: BioVaxys Technology Corporation
Modality: Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

BVX-0320 is a haptenized recombinant protein vaccine candidate developed by BioVaxys Technology for the prevention of COVID-19. The vaccine utilizes a recombinant SARS-CoV-2 spike protein that has been modified through haptenization, a process designed to enhance the immune system's ability to recognize and respond to the viral antigen, particularly by stimulating T-cell activity. BioVaxys partnered with WuXi Biologics for the synthesis of the recombinant spike proteins and engaged Inotiv for preclinical safety and toxicity evaluations to support an Investigational New Drug (IND) application. The asset was part of a portfolio acquisition from IMV Inc. in 2024, though development by BioVaxys dates back to early 2021.

Other names: haptenized SARS-CoV-2 spike protein vaccine

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on BVX-0320.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BVX-0320.

Explore the full profile